SLGL Sol-Gel Technologies Ltd.

7.97
-0.17  -2%
Previous Close 8.14
Open 8
Price To Book 2.96
Market Cap 162,488,120
Shares 20,387,468
Volume 2,764
Short Ratio
Av. Daily Volume 11,896
Stock charts supplied by TradingView

Drug Information

Drug catalyst information is displayed when you hover over / tap on the stage bar graph.

Phase 3 trial to be initiated in 2020 with data due 2021.
SIRS-T
Acne
Phase 3 data due 4Q 2019.
TWIN
Acne
Phase 3 top-line data met primary endpoints - July 8, 2019.
VERED (Epsolay)
Papulopustular rosacea
Proof of concept trial to commence 1Q 2020.
SGT-210
Palmoplantar keratoderma (PPK)